MediPharm Labs Corp. (TSX:LABS)

MediPharm Labs Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	10.81	11.69	17.98	24.15	34.11
Cash & Short-Term Investments	10.81	11.69	17.98	24.15	34.11
Cash Growth	-7.56%	-34.99%	-25.53%	-29.21%	71.30%
Accounts Receivable	7.53	7.51	5.87	12.88	16.92
Inventory	8.02	8.71	9.9	7.78	10.98
Other Current Assets	1.11	5.17	2.89	2.55	3.54
Total Current Assets	27.47	33.08	36.63	93.86	65.55
Net Property, Plant & Equipment	17.6	19.16	25.27	18.11	25.89
Other Intangible Assets	0.68	0.85	1.03	0.04	0.04
Other Long-Term Assets	-	0.64	1	-	0.88
Total Assets	45.74	53.73	63.94	65.5	92.36
Accounts Payable	9.2	7.86	6.75	7.12	6.21
Accrued Expenses	0.52	2.3	1.89	1.74	2.55
Short-Term Debt	0.2	0.34	2.23	0.6	0.11
Unearned Revenue	-	-	-	-	0
Total Current Liabilities	9.93	10.5	10.86	9.46	8.88
Long-Term Debt	-	0.05	0.07	0.03	0.1
Other Long-Term Liabilities	-	-	-	-	0.24
Total Long-Term Liabilities	-	0.05	0.07	0.03	0.34
Total Liabilities	9.93	10.55	10.93	9.49	9.22
Common Stock	201.9	201.21	200.24	191.26	190.55
Additional Paid-in Capital	3.4	29.56	29.53	28.4	21.91
Accumulated Other Comprehensive Income	-0.11	-0.16	-0.04	-	0.03
Retained Earnings	-169.38	-187.43	-176.73	-163.65	-129.34
Shareholders' Equity	35.81	43.18	53.01	56.01	83.15
Total Liabilities & Equity	45.74	53.73	63.94	65.5	92.36
Total Debt	0.2	0.39	2.3	0.63	0.22
Net Cash (Debt)	10.61	11.3	15.69	23.51	33.89
Net Cash Growth	-6.17%	-27.95%	-33.29%	-30.63%	2834.55%
Net Cash Per Share	0.03	0.03	0.04	0.09	0.14
Book Value	35.81	43.18	53.01	56.01	83.15
Book Value Per Share	0.09	0.11	0.15	0.20	0.33
Tangible Book Value	35.14	42.33	51.97	55.97	83.1
Tangible Book Value Per Share	0.08	0.10	0.14	0.20	0.33

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.